| Name | Title | Contact Details |
|---|
Niceville Cash and Carry Inc is a Niceville, FL-based company in the Manufacturing sector.
Groupe Park Avenue Inc. is a Montr, QC-based company in the Manufacturing sector.
The Step2 Company, LLC, headquartered in Streetsboro, Ohio, is the largest American manufacturer of preschool and toddler toys and the world's largest rotational molder of plastics. Step2 began operations in 1991 with five employees and has grown to its present 800-plus full-time employees. Today, Jack Vresics manages Step2 as the President and CEO. Step2 boasts two large US plants in northern Ohio, one in Streetsboro and one in Perrysville. Step2 products are distributed to select retailers throughout the US, Canada, and over 70 other countries. Due to the growing customer demand for products worldwide, Step2 has expanded to a manufacturing site in Saudi Arabia, a distribution center in the United Kingdom, and a licensing agreement between Step2 and The Gunica Company in Korea was arranged to provide additional manufacturing capabilities to supply customers throughout Asia. Step2 is privately held by New York-based Liberty Partners.
BAE Industries is a Center Line, MI-based company in the Manufacturing sector.
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company`s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe™. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the company is currently waiting for regulatory approval to begin the TAVVE first-in-human trial for enVVe.